13F HOLDINGS REPORT
Logos Global Management LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001172661-24-005030
Total Value
$926.8M
Positions
55
Other Managers
0
Confidential Omitted
No
Holdings (55)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IDEAYA BIOSCIENCES INC | IDYA | 2,100,000 | $66.5M | 7.18% |
| 2 | STRUCTURE THERAPEUTICS INC | GPCR | 1,250,000 | $54.9M | 5.92% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 1,200,000 | $54.4M | 5.87% |
| 4 | DISC MEDICINE INC | IRON | 935,000 | $45.9M | 4.96% |
| 5 | JANUX THERAPEUTICS INC | JANX | 1,000,000 | $45.4M | 4.90% |
| 6 | OLEMA PHARMACEUTICALS INC | OLMA | 3,208,875 | $38.3M | 4.13% |
| 7 | VAXCYTE INC | PCVX | 300,000 | $34.3M | 3.70% |
| 8 | IMMUNOVANT INC | IMVT | 1,100,000 | $31.4M | 3.38% |
| 9 | CELLDEX THERAPEUTICS INC NEW | CLDX | 900,000 | $30.6M | 3.30% |
| 10 | OCULAR THERAPEUTIX INC | OCUL | 3,500,000 | $30.4M | 3.29% |
| 11 | IONIS PHARMACEUTICALS INC | IONS | 750,000 | $30.0M | 3.24% |
| 12 | ERASCA INC | ERAS | 10,900,000 | $29.8M | 3.21% |
| 13 | APELLIS PHARMACEUTICALS INC | APLS | 1,000,000 | $28.8M | 3.11% |
| 14 | MERUS N V | N5749R100 | 575,000 | $28.7M | 3.10% |
| 15 | GALAPAGOS NV | GLPGF | 800,000 | $23.0M | 2.48% |
| 16 | AKERO THERAPEUTICS INC | 00973Y108 | 800,000 | $23.0M | 2.48% |
| 17 | DESIGN THERAPEUTICS INC | DSGN | 4,217,627 | $22.7M | 2.45% |
| 18 | VERA THERAPEUTICS INC | VERA | 500,000 | $22.1M | 2.38% |
| 19 | COGENT BIOSCIENCES INC | COGT | 2,000,000 | $21.6M | 2.33% |
| 20 | CYTOKINETICS INC | CYTK | 400,000 | $21.1M | 2.28% |
| 21 | BICARA THERAPEUTICS INC | BCAX | 800,000 | $20.4M | 2.20% |
| 22 | SAREPTA THERAPEUTICS INC | SRPT | 150,000 | $18.7M | 2.02% |
| 23 | ANNEXON INC | ANNX | 2,600,000 | $15.4M | 1.66% |
| 24 | TRAVERE THERAPEUTICS INC | TVTX | 1,100,000 | $15.4M | 1.66% |
| 25 | ENLIVEN THERAPEUTICS INC | ELVN | 495,000 | $12.6M | 1.36% |
| 26 | BEAM THERAPEUTICS INC | BEAM | 500,000 | $12.3M | 1.32% |
| 27 | EDGEWISE THERAPEUTICS INC | EWTX | 450,000 | $12.0M | 1.30% |
| 28 | BICYCLE THERAPEUTICS PLC | BCYC | 500,000 | $11.3M | 1.22% |
| 29 | Y-MABS THERAPEUTICS INC | 984241109 | 800,000 | $10.5M | 1.14% |
| 30 | ARVINAS INC | ARVN | 400,000 | $9.9M | 1.06% |
| 31 | TREVI THERAPEUTICS INC | TRVI | 2,750,000 | $9.2M | 0.99% |
| 32 | NUVALENT INC | NUVL | 75,000 | $7.7M | 0.83% |
| 33 | COMPASS PATHWAYS PLC | CMPS | 1,159,030 | $7.3M | 0.79% |
| 34 | ORUKA THERAPEUTICS INC | ORKA | 257,330 | $6.3M | 0.68% |
| 35 | ROCKET PHARMACEUTICALS INC | RCKTW | 325,000 | $6.0M | 0.65% |
| 36 | SPYRE THERAPEUTICS INC | SYRE | 200,000 | $5.9M | 0.63% |
| 37 | DYNE THERAPEUTICS INC | DYN | 160,000 | $5.7M | 0.62% |
| 38 | ASTRIA THERAPEUTICS INC | 04635X102 | 500,000 | $5.5M | 0.59% |
| 39 | FULCRUM THERAPEUTICS INC | FULC | 1,500,000 | $5.4M | 0.58% |
| 40 | CYBIN INC | HELP | 600,000 | $5.3M | 0.58% |
| 41 | ENGENE HOLDINGS INC | ENGNW | 800,000 | $5.3M | 0.57% |
| 42 | AVALO THERAPEUTICS INC | AVTX | 539,079 | $5.1M | 0.55% |
| 43 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 5,000,000 | $4.5M | 0.49% |
| 44 | RAPPORT THERAPEUTICS INC | RAPP | 208,910 | $4.1M | 0.44% |
| 45 | SILENCE THERAPEUTICS PLC | SLNCF | 200,000 | $3.6M | 0.39% |
| 46 | ATYR PHARMA INC | ATYR | 2,000,000 | $3.5M | 0.38% |
| 47 | NEXTCURE INC | NXTC | 2,500,000 | $3.4M | 0.37% |
| 48 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 416,666 | $2.9M | 0.32% |
| 49 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 145,089 | $2.1M | 0.23% |
| 50 | UNICYCIVE THERAPEUTICS INC | UNCY | 5,078,927 | $2.1M | 0.22% |
| 51 | ALLAKOS INC | 01671P100 | 2,900,000 | $1.9M | 0.20% |
| 52 | NEUMORA THERAPEUTICS INC. | NMRA | 100,000 | $1.3M | 0.14% |
| 53 | IO BIOTECH INC | IOBT | 493,827 | $518,518 | 0.06% |
| 54 | SKYE BIOSCIENCE INC | SKYE | 100,000 | $391,000 | 0.04% |
| 55 | BOUNDLESS BIO INC | BOLD | 58,903 | $204,393 | 0.02% |